Pregnancy-Safe Skincare: The Complete 2026 Ingredient Guide

Pregnancy doesn't have to mean giving up your skincare routine. It does mean reading the ingredient list more carefully and knowing which of the actives you rely on have solid safety data and which carry a precautionary flag. This guide walks through each category with the evidence behind the recommendation, pulled from the American College of Obstetricians and Gynecologists, NHS pregnancy skincare guidance, the EU Scientific Committee on Consumer Safety, and peer-reviewed teratology literature.

In a hurry? Jump to the avoid list, to the safe list, or to the FAQ for pregnancy-specific concerns.

Why "pregnancy-safe" is not a regulated term

Before we name ingredients, a note on the language. "Pregnancy-safe" has no regulatory definition in the European Union, the United Kingdom, or the United States. Cosmetic manufacturers can place this claim on any product without auditable proof. The responsible stance, endorsed by ACOG and the British Association of Dermatologists, is to evaluate each ingredient against three layers of evidence: known teratogenicity in animal or human studies, known percutaneous absorption percentages, and documented clinical safety or precaution signals.

An ingredient with zero teratogenicity signal, negligible absorption, and a long history of clinical use is safe. An ingredient with a demonstrated teratogenicity signal or a regulatory precaution flag should be avoided regardless of how small the absorption is calculated to be. A third category, the "insufficient data" ingredients, is where most conservative obstetric guidance falls: in the absence of evidence of safety, default to precaution.

This framework is why retinoids are flagged while niacinamide is not: not because every user of topical retinol will harm their baby (the absolute risk from topical application is low), but because the class includes oral analogues with documented teratogenicity, and because ACOG policy prioritises precaution over optimism for the nine to ten months of pregnancy.

The avoid list: seven categories with evidence

1. Oral retinoids and prescription topical retinoids

Status: Absolute contraindication (oral), relative contraindication (topical prescription strength).

Oral isotretinoin is the most teratogenic medication in clinical use in dermatology. Documented birth defects include craniofacial malformations, cardiovascular defects, thymic abnormalities, and central nervous system malformations, with an estimated 20 to 35% rate of serious birth defects in pregnancies exposed during the first trimester (Benke 1984, JAMA). Pregnancy testing and two-method contraception are mandatory for all patients on oral isotretinoin under the iPLEDGE program in the US and equivalent schemes in the EU.

Prescription topical retinoids (tretinoin, adapalene, tazarotene) have lower absolute percutaneous absorption, estimated at under 2% systemic exposure. Published data on topical tretinoin exposure during pregnancy is mixed, with no clear teratogenicity signal at typical cosmetic concentrations, but multiple case reports of malformations following topical use keep ACOG and FDA guidance conservative. The practical recommendation: discontinue all retinoids (oral and topical, prescription and over-the-counter) from the moment you plan conception through breastfeeding.

2. Over-the-counter retinol and retinaldehyde

Status: Relative contraindication. Discontinue as a precaution.

Cosmetic retinol converts to retinoic acid in the skin through a two-step enzymatic process. The conversion rate is low (estimated 5 to 10% of applied retinol reaches retinoic acid form in viable epidermis), and percutaneous systemic absorption at leave-on cosmetic concentrations (0.01 to 0.3% under SCCS 2023 cap) is a small fraction of the applied dose. In absolute terms, topical retinol at cosmetic concentrations is unlikely to produce teratogenic exposure comparable to oral vitamin A.

That said, ACOG, NHS, and all major dermatology societies recommend discontinuation during pregnancy as a precaution, because no pregnancy-exposed cohort exists large enough to rule out rare adverse outcomes, and because safe alternatives with comparable benefit exist. Azelaic acid and niacinamide handle most of retinol's typical use cases (acne, hyperpigmentation, barrier support) without the precaution flag.

3. Salicylic acid above 2%

Status: Avoid above 2%. Rinse-off use at 2% is generally acceptable.

Salicylic acid is a beta hydroxy acid related to aspirin. High-dose oral aspirin in late pregnancy is associated with premature closure of the ductus arteriosus and other complications. Topical salicylic acid at low concentrations (2% in typical cleansers) produces negligible systemic absorption, and ACOG does not restrict it. At higher concentrations (chemical peels at 20 to 30%, prescription-strength leave-on) the systemic exposure rises and the same precaution applies as for oral aspirin.

Practical guidance: a 2% salicylic acid cleanser used once daily is generally accepted by NHS and ACOG. A 20% peel or a 5% leave-on serum is not. Check the concentration on your product label.

4. Hydroquinone

Status: Avoid.

Hydroquinone is a depigmenting agent used in prescription strength for melasma and post-inflammatory hyperpigmentation. Topical hydroquinone at 2 to 4% produces up to 35% systemic absorption per application (Wester 1983 systemic absorption study), which is dramatically higher than most other cosmetic actives. While direct teratogenicity has not been demonstrated, the combination of high absorption and lack of pregnancy-exposed outcome data pushes all major guidance into the "avoid" category. Hydroquinone is already banned in EU cosmetics (since 2001 under the Cosmetics Regulation Annex II), but it remains available over-the-counter in the US. Check imported US products.

5. Formaldehyde-releasing preservatives

Status: Avoid.

Preservatives in this family include DMDM hydantoin, imidazolidinyl urea, diazolidinyl urea, quaternium-15, and bronopol (2-bromo-2-nitropropane-1,3-diol). They work by slowly releasing formaldehyde to inhibit microbial growth. Formaldehyde is classified as a known human carcinogen per the IARC monograph list and a documented contact allergen, and during pregnancy the precautionary approach removes unnecessary cumulative exposure. These preservatives are found primarily in mass-market US cosmetics and hair products; EU formulations increasingly use alternatives like phenoxyethanol + ethylhexylglycerin blends.

6. Chemical sunscreens containing oxybenzone

Status: Avoid oxybenzone specifically. Other chemical filters acceptable case by case.

Oxybenzone (also listed as benzophenone-3) has demonstrated measurable systemic absorption and crosses the placental barrier (Krause et al. 2012 IJAA). While direct teratogenicity is not demonstrated, animal studies have raised endocrine-disruption concerns, and a 2019 FDA study demonstrated plasma concentrations from single-application sunscreen use. For pregnancy, mineral sunscreens (zinc oxide, titanium dioxide) are the consensus safer choice: they sit on the skin surface rather than absorbing.

Other chemical filters (avobenzone, octocrylene, tinosorb) have lower absorption profiles and are considered acceptable for pregnancy use in European guidance, but if you have the choice between chemical and mineral SPF, mineral is the pregnancy-simpler option.

7. High-concentration essential oils

Status: Avoid concentrated oils of sage, rosemary, peppermint, tea tree, camphor, eucalyptus.

Several essential oils have uterotonic (uterus-stimulating) activity at high concentrations documented in aromatherapy literature, including clary sage, peppermint, rosemary and eucalyptus. Low-concentration diluted use in cosmetic products is generally considered acceptable by ACOG, but leave-on products with essential oils as top-10 INCI ingredients should be reviewed case by case. Tea tree oil carries a separate concern: it is one of the leading contact allergens in cosmetic patch-testing, and pregnancy skin is more reactive, so even setting aside theoretical systemic effects, the allergen risk alone supports avoidance.

The safe list: what to keep using

The following ingredients have either negligible systemic absorption, long-established safety data, or active positive endorsement from ACOG or NHS pregnancy guidance.

Niacinamide: Comprehensively safe. ACOG does not restrict. NHS categorises as low-risk. Dietary niacinamide intake during pregnancy is already in the 14 to 18 mg/day range, far above anything topical absorption would contribute. See our full niacinamide safety review.

Hyaluronic acid: Topical HA has essentially zero systemic absorption due to molecular size. Safe at all concentrations and all formats.

Glycerin: Safe. Natural skin component, zero restriction.

Ceramides (NP, AP, EOP): Safe. Identical to skin's native lipid structure.

Glycolic acid and lactic acid up to 10%: Alpha hydroxy acids at typical cosmetic concentrations (5 to 10%) have negligible systemic absorption. ACOG and NHS accept continued use. At higher concentrations (peels at 20%+) the precaution shifts toward professional guidance.

Azelaic acid: Safe and positively recommended as an alternative to retinol during pregnancy for acne and hyperpigmentation. EU CosIng lists it without pregnancy restriction. Widely prescribed off-label for pregnancy-appropriate acne management.

Vitamin C (L-ascorbic acid and stable derivatives): Safe. Water-soluble, negligible systemic effect from topical use, no teratogenicity signal.

Peptides: Safe. Large molecule structure means minimal percutaneous absorption, and peptide-based actives have no documented pregnancy concerns.

Mineral sunscreens (zinc oxide, titanium dioxide): Positively recommended. Sit on skin surface, essentially zero absorption, full UV protection. The default pregnancy SPF choice.

Benzoyl peroxide (topical): ACOG accepts topical use in low concentrations (2.5 to 5%) for acne. Systemic absorption is negligible. Prescription-strength 10% still requires physician guidance.

Sulfur: Safe. Used historically in acne preparations, no pregnancy restriction.

Melasma (the pregnancy "mask"): Hormonal changes trigger pigmentation in 50 to 70% of pregnancies. First-line treatment during pregnancy is strict sun protection (mineral SPF 50+ daily, reapplied) plus azelaic acid 10 to 20% and vitamin C. Avoid hydroquinone. Post-partum, once you have stopped breastfeeding, standard hydroquinone or tranexamic acid protocols become options again.

Acne during pregnancy: Triggered by hormonal shifts, often peaks in the second trimester. First-line topicals during pregnancy: benzoyl peroxide 2.5 to 5%, azelaic acid 15 to 20%, salicylic acid 2% in rinse-off form, glycolic acid up to 10%. Avoid all retinoids. If the acne is severe, dermatology consultation is appropriate because some prescription topical antibiotics (erythromycin, clindamycin) remain acceptable under specialist supervision.

Stretch marks: No topical ingredient has proven efficacy for preventing or reversing striae gravidarum in randomised controlled trials. A 2012 Cochrane review found insufficient evidence for any specific preparation. The ingredients most commonly marketed (cocoa butter, vitamin E, centella asiatica) are pregnancy-safe but are working on a problem with genetic and mechanical determinants that topicals cannot fully address.

Itchy skin: Common in the third trimester. Gentle emollients (ceramide creams, petrolatum, shea butter) and colloidal oatmeal baths are the accepted interventions. Persistent severe itch, especially on palms and soles, warrants medical evaluation to rule out cholestasis of pregnancy.

Breastfeeding: what changes after birth

Breastfeeding has a narrower avoid list than pregnancy, primarily because the foetal organogenesis concerns no longer apply. However, several ingredients either transfer into breast milk or raise infant-exposure concerns.

Continue to avoid oral isotretinoin (absolute contraindication during breastfeeding). Topical retinoids remain on the precaution list, particularly for areas where the infant may have skin contact. Salicylic acid chemical peels remain on the avoid list due to absorption variability.

Ingredients that were safe in pregnancy generally remain safe during breastfeeding. NHS and La Leche League both confirm niacinamide, hyaluronic acid, ceramides, AHAs at standard concentrations, and mineral sunscreens as compatible.

FAQ

Can I use retinol during the first trimester if I didn't know I was pregnant? Most dermatologists will tell you not to panic. Studies of first-trimester topical retinol exposure have not demonstrated elevated rates of birth defects at cosmetic concentrations, though the published cohorts are small. Stop use immediately, inform your obstetrician, and continue with the alternatives (azelaic acid, niacinamide). The same logic applies to topical salicylic acid at any concentration.

Is bakuchiol a true retinol alternative during pregnancy? Bakuchiol is a plant-derived compound marketed as a retinol alternative. Published data on mechanism and efficacy exists (including a 2019 British Journal of Dermatology head-to-head trial), but pregnancy safety data specifically is absent. Most dermatologists treat it as presumed-safe based on the absence of teratogenicity signal, but ACOG has not issued a specific opinion. If you want the most documented pregnancy-safe anti-ageing option, azelaic acid plus vitamin C plus peptides is the evidence-based combination.

Can I use chemical peels during pregnancy? Glycolic and lactic acid peels at 10 to 30% by a licensed professional are generally considered acceptable. Salicylic acid peels above 2% are not. TCA peels are not recommended. Professional consultation is mandatory for any peel during pregnancy because protocols and choices vary.

What about hair dye? Outside the scope of skincare, but since it is the most common adjacent question: ACOG notes that modern hair dye has very limited scalp absorption and considers it low-risk in pregnancy. Highlights, balayage, and similar techniques that do not contact the scalp are the lowest-risk options. Traditional root touch-ups with ammonia-containing permanent dyes have the weakest pregnancy safety signal because of absorption and fume exposure, not because of teratogenicity.

Is "natural" or "organic" skincare safer during pregnancy? No. "Natural" and "organic" are marketing terms with no regulated pregnancy-safety definition. As shown in the avoid list, essential oils in concentrated form are among the ingredients to avoid, and those are typically marketed as natural. Read the INCI, not the front-of-package claims.

Sources

American College of Obstetricians and Gynecologists. "Skin Conditions During Pregnancy." FAQ 169. acog.org/womens-health/faqs/skin-conditions-during-pregnancy
NHS. "Which medicines can I use in pregnancy and while breastfeeding?" nhs.uk
EU Scientific Committee on Consumer Safety. Opinion on Vitamin A (SCCS/1639/21). Leave-on retinol capped at 0.3%. health.ec.europa.eu/scientific-committees
Benke PJ. "The isotretinoin teratogen syndrome." JAMA, 1984. PubMed: 6481694
Wester RC, Maibach HI. "Percutaneous absorption of hydroquinone." Journal of Investigative Dermatology, 1983. PubMed: 6841617
Krause M, et al. "Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UV-filters." International Journal of Andrology, 2012. PubMed: 22591333
Dhaliwal S, et al. "Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing." British Journal of Dermatology, 2019. PubMed: 29752714
Brennan M, et al. "Topical preparations for preventing stretch marks in pregnancy." Cochrane Database of Systematic Reviews, 2012. Cochrane review
EU CosIng database. ec.europa.eu/growth/tools-databases/cosing

For a scored assessment of any specific pregnancy-appropriate product, see the SkinScore rankings where every product gets a dedicated safety sub-score. To decode any ingredient on your current product, check the ingredient encyclopedia. For the full scoring methodology, read the methodology page.

For further reading

Related articles:

Resources: